NM_006164.5(NFE2L2):c.613G>C (p.Asp205His) AND not specified
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Oct 3, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV004157095.1
Allele description [Variation Report for NM_006164.5(NFE2L2):c.613G>C (p.Asp205His)]
NM_006164.5(NFE2L2):c.613G>C (p.Asp205His)
Condition(s)
- Synonyms:
- AllHighlyPenetrant
- Identifiers:
- MedGen: CN169374
-
ATP synthase F0 subunit 6 (mitochondrion) [Cabassous unicinctus]
ATP synthase F0 subunit 6 (mitochondrion) [Cabassous unicinctus]gi|959123777|ref|YP_009184288.1|Protein
-
rubrerythrin [Methanohalophilus mahii]
rubrerythrin [Methanohalophilus mahii]gi|502801570|ref|WP_013036546.1|Protein
-
Clofibric Acid
Clofibric AcidAn antilipemic agent that is the biologically active metabolite of CLOFIBRATE.<br/>Year introduced: 1991(1980)MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 3, 2024